HomeAbout

TL;DR CNBC


People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey - TL;DR CNBC

People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey

Publishing timestamp: 2024-01-09 09:38:43


Summary

A survey by Deutsche Bank found that calorie consumption declines when patients take GLP-1 medication like Novo Nordisk's Ozempic or Wegovy. However, once the medication is stopped, the number of calories consumed by patients will rise again, and in some cases, it will be even higher than before treatment. The survey also found that the impact of anti-obesity medications on food and beverage stocks needs to be assessed in the context of all weight loss programs. Compliance with anti-obesity medications is low, similar to other chronic disease medications. Deutsche Bank expects interest in weight loss programs to be peaking, which could be a good time for investors to hold food and beverage stocks.


Sentiment: MIXED

Tickers: ULVR-GBULNSRGFMDLZNOVO.B-DKNES.N-CHLLYKHCCPUH

Keywords: breaking news: investingunilever plceli lilly and conestle samondelez international inckraft heinz coinvestment strategynovo nordisk a/scompute health acquisition corpbusiness newsstock markets

Source: https://www.cnbc.com/2024/01/08/post-ozempic-patients-may-eat-more-calories-deutsche-bank-survey-finds.html


Developed by Leo Phan